Results 91 to 100 of about 14,777,258 (301)

Investigation the Effective atomic number , electron density, Half value layer and mean free path of steel types304and 347 in the energy range 40KeV-130KeV [PDF]

, 2013
Effective atomic number (Zeff) ,electron densities (Nel) , half value layer(HVL)and  mean free path (mfp) has been determined with the help of semi-empirical relations for Stainless steel of types: 304 and 347  at  energy range  40-130keV .The effective ...
Al-Jaff, Sabah Mahmoud Aman Allah
core   +1 more source

Atomic Energy Commission Report NP-283

, 1949
The following document is a collection of investigative reports on the victims of the atomic bomb in Japan. Information covers injuries, how the victim was found, if they were protected, where they were when the bomb went off, radiation effects, and ...
Joint Commission for the Investigation of the Effects of the Atomic Bomb in Japan
core  

Studies on mass attenuation coefficient, effective atomic number and electron density of some vitamins

, 2012
Mass attenuation coefficient, , atomic cross-section, , electronic cross-section, , effective atomic number, and effective electron density, , were determined experimentally and theoretically for some vitamins (retinol, beta-carotene, thiamine ...
Demir, Demet, TURŞUCU, A., ÖZNÜLÜER, Tuba   +2 more
core   +1 more source

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

Molecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce, Simone Bini, Marialuisa Sponziello, Giorgio Grani, Giulia Fiscon, Paola Paci, Lorenzo Farina, Rosa Falcone, Valentina Maggisano, Sebastiano Filetti, Cosimo Durante, Antonella Verrienti   +11 more
wiley   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Monte Carlo Code for Calculating the Elastic and Inelastic Scattering Cross Section Along with Mean Free Path of Positron Scattering in Kidney, Lung and Thyroid Organs

East European Journal of Physics
This research calculated the total cross sections for positron scattering in kidney, lung, and thyroid tissues along an energy range of 100 eV to 1 MeV.
Hawar M. Dlshad, Jamal M. Rashid
doaj   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

APDA Bulletin 123

, 1957
Progress report issued by the APDA over research and development activities of the Enrico Fermi Atomic Power Plant.
Atomic Power Development Associates
core  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Atomic Energy Commission Report TID-7010

, 1957
Introduction: Atomic Energy Facts is designed to serve as an introduction to nuclear operations in the United States and as a handbook of related information for the use of industrial firms and other active or interested in atomic ...
U.S. Atomic Energy Commission
core